Metabolic Syndrome

Clinical Trial Finder

Many patients with metabolic syndrome are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effects of Bariatric Surgery on Inspiratory Metaboreflex in Obese Subjects

Conditions:   Obesity;   Metabolic Syndrome
Interventions:   Other: Bariatric surgery;   Other: Control
Sponsor:   University of Cruz Alta
Recruiting - verified February 2017

Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study

Condition:   Metabolic Syndrome
Intervention:   Other: Personalized recommendations for diet
Sponsor:   Galilee CBR
Not yet recruiting - verified February 2017

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Condition:   Metabolic Syndrome
Intervention:   Drug: 3-V Bioscience-2640
Sponsors:   University of Missouri-Columbia;   3V Biosciences, Inc.
Recruiting - verified October 2016

Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines

Condition:   Overweight and Obesity
Intervention:  
Sponsor:   Tungs’ Taichung Metroharbour Hospital
Completed - verified February 2017

A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults

Condition:   Metabolic Syndrome
Interventions:   Other: "Grab-and-Go" meal plan;   Other: "Jump-Start" meal plan
Sponsors:   University of Missouri-Columbia;   Robert C. Atkins Foundation
Active, not recruiting - verified August 2016

Breast Cancer WEight Loss Study (BWEL Study)

Condition:   Breast Carcinoma
Interventions:   Other: Health Education Program;   Other: Weight Loss Intervention
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI);   Division of Cancer Control;   NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)
Recruiting - verified February 2017

Phlebotomy and Polycystic Ovary Syndrome

Conditions:   Hyperandrogenism;   Metabolic Cardiovascular Syndrome
Interventions:   Procedure: Phlebotomy;   Drug: ethinylestradiol;   Drug: Cyproterone Acetate
Sponsors:   Manuel Luque Ramírez;   Instituto de Salud Carlos III
Recruiting - verified February 2017

Canola Oil Multi-center Intervention Trial II

Conditions:   Cardiovascular Disease;   Metabolic Syndrome
Interventions:   Other: Canola Oil;   Other: High oleic acid canola oil;   Other: Western diet oil combination
Sponsors:   Penn State University;   Canola Council of Canada;   University of Manitoba;   Laval University;   St. Michael's Hospital, Toronto;   St. Boniface General Hospital Research Centre
Completed - verified February 2017

Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

Conditions:   Infant, Premature, Diseases;   Infant, Small for Gestational Age
Interventions:   Dietary Supplement: Individualized Nutrition;   Dietary Supplement: Optimized nutrition
Sponsors:   University of Texas Southwestern Medical Center;   Children's Medical Center Dallas;   The Gerber Foundation
Recruiting - verified February 2017

Galantamine Effects in Patients With Metabolic Syndrome

Condition:   Abdominal Obesity Metabolic Syndrome
Interventions:   Drug: Galantamine;   Drug: Placebo (for galantamine)
Sponsors:   University of Sao Paulo;   University of Nove de Julho;   Feinstein Institute for Medical Research
Completed - verified February 2017

Research Aimed at Improving Both Mood and Weight

Conditions:   Depression;   Obesity
Intervention:   Behavioral: RAINBOW Intervention Program
Sponsors:   Palo Alto Medical Foundation;   National Heart, Lung, and Blood Institute (NHLBI);   University of Washington;   University of Pittsburgh;   Stanford University;   University of Illinois at Chicago
Active, not recruiting - verified February 2017

Stress and Sugar Synergy

Conditions:   Metabolic Syndrome;   Insulin Resistance;   Dyslipidemia
Interventions:   Other: orange juice;   Other: sucrose
Sponsors:   University of California, Davis;   University of California, San Francisco;   USDA, Western Human Nutrition Research Center
Recruiting - verified December 2016

Canola Oil, Fibre and DHA Enhanced Clinical Trial

Condition:   Metabolic Syndrome
Interventions:   Dietary Supplement: Butter, sunflower and safflower oil;   Dietary Supplement: High Oleic Canola Oil and DHA (HOCO-DHA);   Dietary Supplement: Barley beta-glucan;   Dietary Supplement: HOCO-DHA and Barley beta-glucan
Sponsors:   University of Manitoba;   Canadian Institutes of Health Research (CIHR);   Agriculture and Agri-Food Canada
Completed - verified February 2017

Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage

Conditions:   Metabolic Syndrome;   Insulin Resistance;   DNA Damage
Interventions:   Dietary Supplement: Blueberry Powder;   Dietary Supplement: Placebo
Sponsors:   Children's Hospital & Research Center Oakland;   U.S. Highbush Blueberry Council;   USDA Agricultural Research Station in Albany, CA
Enrolling by invitation - verified February 2017

Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial

Condition:   Metabolic Syndrome
Intervention:   Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
Sponsors:   Family Medicine Residency of Idaho;   Mountain States Group;   Saint Alphonsus Medical Group;   Quantified, Inc.
Withdrawn - verified February 2017

Study of a Holistic Health Program for United Methodist Clergy

Conditions:   Obesity;   Depression;   Diabetes;   Hypertension;   Hypercholesterolemia
Intervention:   Behavioral: Holistic health
Sponsors:   Duke Clergy Health Initiative;   The Duke Endowment
Completed - verified February 2017

Relationship Between Gestational Diabetes and Type 2 Diabetes

Conditions:   Gestational Diabetes;   Type 2 Diabetes
Intervention:  
Sponsor:   Laval University
Active, not recruiting - verified February 2017

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Conditions:   Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:  
Sponsors:   Massachusetts General Hospital;   National Alliance for Research on Schizophrenia and Depression
Terminated - verified February 2017

LAGB as a Treatment for Morbid Obesity in Adolescents

Conditions:   Morbid Obesity;   Obstructive Sleep Apnea Syndrome;   Metabolic Syndrome;   Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:   Device: Laparoscopic adjustable gastric banding (Allergan Lap Band)
Sponsor:   Jeffrey L Zitsman, MD
Completed - verified February 2017

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Condition:   Nonalcoholic Fatty Liver Disease
Intervention:  
Sponsor:   Vanderbilt University
Enrolling by invitation - verified February 2017

Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

Condition:   Hypertriglyceridemia With the Metabolic Syndrome
Intervention:   Drug: Fenofibrate (drug)
Sponsors:   University of Michigan;   Abbott
Completed - verified February 2017